acute lymphoblastic leukemia

Showing 1 - 25 of 414

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

B-All, Acute Lymphoblastic Leukemia Trial run by the National Cancer Institute (NCI) (NGS testing)

Not yet recruiting
  • B-All
  • Acute Lymphoblastic Leukemia
  • NGS testing
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 30, 2022

Acute Lymphoblastic Leukemia, Lymphoma, Multiple Myeloma Trial in Taiyuan (CAR-T Autologous T cell injection)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • CAR-T Autologous T cell injection
  • Taiyuan, Shanxi, China
    Shanxi Bethune Hospital
Nov 23, 2022

Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial (drug, radiation, procedure)

Not yet recruiting
  • Acute Leukemia
  • +4 more
  • (no location specified)
Oct 18, 2022

l Parenting Skills As A Novel Target for Improving Pediatric

Recruiting
  • Acute Lymphoblastic Leukemia
  • Survey Administration
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 19, 2022

Acute Lymphoblastic Leukemia Trial in Tianjin (CN201)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Oct 14, 2022

Acute Lymphoblastic Leukemia Trial in Tampa (Hyper CVAD Protocol (Standard of Care Multi-Agent Chemotherapy), Calaspargase

Recruiting
  • Acute Lymphoblastic Leukemia
  • Hyper CVAD Protocol (Standard of Care Multi-Agent Chemotherapy)
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Oct 12, 2022

Acute Lymphoblastic Leukemia Trial in Suzhou (Cladribine, Fludarabine)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Oct 12, 2022

Acute Lymphoblastic Leukemia Trial in Sanhe (CAR-NK-CD19 Cells)

Recruiting
  • Acute Lymphoblastic Leukemia
  • CAR-NK-CD19 Cells
  • Sanhe, Hebei, China
    Hebei Yanda Ludaopei Hospital
Sep 29, 2022

Tisagenlecleucel in Brazilian Acute Lymphoblastic Leukemia or

Not yet recruiting
  • Diffuse Large B-cell Lymphoma
  • Acute Lymphoblastic Leukemia
  • tisagenlecleucel
  • (no location specified)
Sep 13, 2022

Acute Lymphoid Leukemia, Acute Lymphoblastic Leukemia Trial in Aurora (CD19 Directed CAR T Cell)

Not yet recruiting
  • Acute Lymphoid Leukemia
  • Acute Lymphoblastic Leukemia
  • CD19 Directed CAR T Cell
  • Aurora, Colorado
    University of Colorado Hospital
Sep 12, 2022

Acute Lymphoblastic Leukemia, Myeloblastic Leukemia, Biphenotypic Acute Leukemia Trial (GVHD prevention: post-transplantation

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +5 more
  • GVHD prevention: post-transplantation cyclophosphamide, abatacept, vedolizumab, calcineurin inhibitor
  • (no location specified)
Aug 23, 2022

Acute Lymphoblastic Leukemia, Leukemia Trial in Houston (Ponatinib, Venetoclax, Mini-hyper CVD)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Leukemia
  • Houston, Texas
    MD Anderson Cancer Center
Aug 23, 2022

Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,

Recruiting
  • Acute Erythroid Leukemia
  • +10 more
  • San Francisco, California
  • +4 more
Aug 22, 2022

Acute Lymphoblastic Leukemia Trial in Memphis (Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia

Completed
  • Acute Lymphoblastic Leukemia
  • Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine
  • Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Etoposide, Dasatinib
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jul 26, 2022

Pediatric Acute Lymphoblastic Leukemia in the United States

Recruiting
  • Acute Lymphoblastic Leukemia
  • Electronic Health Record Review
  • +2 more
  • Oakland, California
  • +17 more
Aug 17, 2022

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Uijeongbu si (Asciminib single agent, Asciminib, Imatinib)

Recruiting
  • Chronic Myelogenous Leukemia
  • Acute Lymphoblastic Leukemia
  • Asciminib single agent
  • +5 more
  • Uijeongbu si, Gyeonggi Do, Korea, Republic of
    Novartis Investigative Site
Aug 17, 2022

Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Duarte (Best Practice, Internet-Based

Recruiting
  • Acute Leukemia
  • +3 more
  • Best Practice
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Aug 15, 2022

Acute Lymphoblastic Leukemia, Hepatotoxicity Trial in Orange (Levocarnitine)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • Hepatotoxicity
  • Orange, California
  • +1 more
Aug 12, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +26 more
Aug 11, 2022

Acute Lymphoblastic Leukemia Trial in United States (Calaspargase pegol (S95015))

Recruiting
  • Acute Lymphoblastic Leukemia
  • Calaspargase pegol (S95015)
  • Scottsdale, Arizona
  • +10 more
Aug 8, 2022

Colorectal Cancer, Hematologic Malignancy, Rectum Cancer Trial in Cleveland (Vactosertib, Fludarabine Phosphate,

Not yet recruiting
  • Colorectal Cancer
  • +11 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Aug 2, 2022

Acute Lymphoblastic Leukemia Trial in Saint Louis (Family-based Behavioral Weight Loss Treatment)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Family-based Behavioral Weight Loss Treatment
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 27, 2022

Acute Lymphoblastic Leukemia Trial in Worldwide (Blinatumomab, AMG 404, Dexamethasone Premedication)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • Duarte, California
  • +18 more
Jul 27, 2022

Patients With Acute Leukemia Infected by COVID-19

Completed
  • Acute Myeloblastic Leukemia
  • +2 more
    • Amiens, France
    • +26 more
    Jul 26, 2022

    Relapsed/Refractory Leukemias, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia Trial in Kansas City, Cincinnati

    Recruiting
    • Relapsed/Refractory Leukemias
    • +4 more
    • Kansas City, Missouri
    • +1 more
    Jul 18, 2022